Medicines Seized From Roorkee Unit Fail Lab Tests

Roorkee : Several packets of branded medicines, which were allegedly being manufactured in a local pharma factory, have failed lab tests. A joint team of state drug control department and police had seized a high volume of alleged fake medicines worth Rs 1.7 crore from a small-sized pharmaceutical industry in Roorkee in August this year. Police had arrested Praveen Tyagi, the owner of the pharma unit, and his aide on the day of the raid itself. A cash amount of Rs 4.65 lakh was also recovered from their possession.

According to reports, the officials from the drug control department and the local police had raided an illegal pharma manufacturing company at Madhopur village near Roorkee and seized medicines of around 200 brands worth Rs 1.7 crore. Police had recovered raw materials, wrappers, aluminium foils, and packaging materials from the spot.

“We had sent 10 samples collected from the unit. They have now been found as ‘spurious’ in the state laboratory tests. The accused Tyagi and his associate are in jail. After this report, the release of the offenders on bail would become difficult,” said MS Rana, drug inspector, Haridwar.

Related Posts

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

New Delhi: In a major crackdown on the sale of expired and substandard products, the Central Range team of Delhi Police Crime Branch has arrested one person and seized nearly…

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

Washington:  On March 18, 2026, the U.S. Food and Drug Administration (FDA) issued a draft guidance titled General Considerations for the Use of New Approach Methodologies in Drug Development. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

US market to dent India pharma earnings even as domestic growth remains firm

US market to dent India pharma earnings even as domestic growth remains firm

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg